Article info
PDFA difficult case
Anti-collapsin response mediator protein 5 encephalitis masquerading as a low-grade brain tumour
- Correspondence to Dr Thomas E Cope, Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 0QQ, UK; thomascope{at}gmail.com
Citation
Anti-collapsin response mediator protein 5 encephalitis masquerading as a low-grade brain tumour
Publication history
- Accepted April 27, 2016
- First published May 31, 2016.
Online issue publication
September 14, 2016
Article Versions
- Previous version (14 September 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
Other content recommended for you
- Central nervous system neuronal surface antibody associated syndromes: review and guidelines for recognition
- Autoimmune choreas
- Seronegative limbic encephalitis: case report, literature review and proposed treatment algorithm
- Paraneoplastic syndromes: when to suspect, how to confirm, and how to manage
- Republished review: Autoantibody testing in encephalopathies
- Autoantibody testing in encephalopathies
- Onco-neural antibodies and tumour type determine survival and neurological symptoms in paraneoplastic neurological syndromes with Hu or CV2/CRMP5 antibodies
- Tourette’s syndrome: a cross sectional study to examine the PANDAS hypothesis
- Chorea and related disorders
- An older man with memory impairment and convulsions